GenSight Biologics S.A. GSGTF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -5.97M | -6.01M | -2.95M | -2.96M | -3.95M |
| Total Depreciation and Amortization | 119.80K | 120.50K | 170.50K | 171.30K | 97.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.08M | 1.09M | 736.30K | 739.50K | 80.60K |
| Change in Net Operating Assets | 3.87M | 3.89M | -1.86M | -1.87M | 2.38M |
| Cash from Operations | -904.30K | -909.70K | -3.91M | -3.92M | -1.40M |
| Capital Expenditure | -38.40K | -38.60K | -2.30K | -2.30K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.20K | -1.20K | 137.90K | 138.50K | -30.10K |
| Cash from Investing | -39.50K | -39.80K | 135.60K | 136.20K | -30.10K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -88.00K | -88.00K | -450.00K | -450.00K | -177.00K |
| Issuance of Common Stock | 464.50K | 464.50K | 2.73M | 2.73M | 362.00K |
| Repurchase of Common Stock | -4.00K | -4.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 124.50K | 124.50K | 2.04M | 2.04M | -29.50K |
| Cash from Financing | 578.10K | 581.50K | 5.02M | 5.04M | 176.50K |
| Foreign Exchange rate Adjustments | -66.30K | -66.70K | -1.70K | -1.80K | 4.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | 600.00 | 600.00 | -600.00 |
| Net Change in Cash | -432.10K | -434.70K | 1.25M | 1.25M | -1.25M |